The sum prevalence of those rearrangements plus all KMT2A rearrangements, the most common of which is still the t(9;11) [KMT2A::MLLT3] fusion, accounts for 39–55% of pediatric AML [32]. Here, MLLT3 is linked to acute myeloid leukemia.